Shopping Cart
- Remove All
- Your shopping cart is currently empty
ZLWT-37 is a potent, orally active inhibitor of CDKs, specifically targeting CDK9 (IC50: 0.002 μM) and CDK2 (IC50: 0.054 μM), and is capable of blocking the cell cycle of HCT116 cells in G2/M phase and inducing apoptosis.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 10-14 weeks | |
50 mg | $1,980 | 10-14 weeks | |
100 mg | $2,500 | 10-14 weeks |
Description | ZLWT-37 is a potent, orally active inhibitor of CDKs, specifically targeting CDK9 (IC50: 0.002 μM) and CDK2 (IC50: 0.054 μM), and is capable of blocking the cell cycle of HCT116 cells in G2/M phase and inducing apoptosis. |
Molecular Weight | 464 |
Formula | C26H30ClN5O |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.